Senior insider sale
SVP, CHIEF OPERATING OFFICER at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$1.36M
20K shares
What this filing means
CAUDILL CORTNEY plans to sell 20K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $1.36M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001950047-26-002360
Officer· SVP, CHIEF OPERATING OFFICER
Since Feb 2026
20K
Shares to sell
$1.36M
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
3/9/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Exercise of options under a registered plan Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$1.36M
3/9/2026
Total
Units
20K
Value
$1.36M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/9/2026 | 20K | $1.36M | NASDAQ | Planned |
| Total | 20K | $1.36M | ||